cells. This is the first demonstration of the potential contribution of anti-receptor antibodies to the therapy and prevention of respiratory disease.
Materials and Methods
Bacterial Strains and Cultivation Conditions. Virulent strains Br (clinical isolate [4] ) and BP338 (derivative of Tohama I [5] ) were grown on Bordet-Gengou agar (lot 689592 ; Difco Laboratories Inc., Detroit, MI) containing 157o sheep blood and 1% glycerol for 48 h, were transferred to Stainer Scholte medium for 48 h, harvested into Medium 199S (M. A. Bioproducts, Walkersville, MD), and adjusted to a concentration of 5 x 109 B. pertussis/ml (1, 4) . Then, 0.5 ml of the bacterial suspension was aliquoted into tubes containing one of the following as listed in Tables I and II: simple carbohydrates (Sigma Chemical Co., St. Louis, MO) at between 10' and 10_ 2 M, complex carbohydrates (Calbiochem-Behring Corp., LaJolla, CA) at between 0.005 and 2.5 mg/ml, mAbs (purified ascites fluid, C. A. Schoenenberger, Universitat Basel, Basel, Switzerland) at between 0.03 and 160 wg protein/ml, and lectins (Sigma Chemical Co.) at 250 wg/ml. Control organisms received no additions. All mixtures were incubated for 30 min in a stationary water bath at 37°C, passed three times through a 21-gauge needle, and then exposed to ciliated cells for the adherence assay.
Radiolabeled B. pertussis strain BP338 was prepared by transfer from Bordet Gengou agar to Stainer Scholte medium containing 15S methionine (0.07 Ci/ml, New England Nuclear, Boston, MA) for 48 h.
Adherence Assay. The assay was performed as described previously using 0.5 ml of a suspension of human ciliated epithelial cells in Medium 199S (5 x 105 cells/ml) for each test condition (4) . Respiratory epithelial cells were obtained by the brushing ofapparently normal human trachea during bronchoscopy. For some assays, ciliated cells were pre-incubated for 30 min at 37oC with one of the above-mentioned potential inhibitors ofadherence (carbohydrates, antibodies, or lectins) or with Clostridium perfringens neuraminidase (200 ug/ml; Sigma Chemical Co.). This treatment was followed by washing (250 g at 4°C), resuspension in 0.5 ml of Medium 1995, and finally, exposure to the bacteria. For all assays, organisms and ciliated cells were incubated together for 3 h at 37oC on a tumbler. Ciliated cells were then washed free of nonadherent bacteria over a 3-wm polycarbonate membrane filter (Nuclepore Corp., Pleasanton, CA), spread on a slide, and dried. Adherent bacteria were stained with a 1 :40 dilution ofbacterial fluorescent antibody (Difco Laboratories, Inc.) by a direct-antibody technique . Slides were read in a coded fashion by one of us (E. Tuomanen) (4) . Results were expressed as the mean number of bacteria adherent to cilia on 25 cells .
Detection of Antibody or Adhesin Binding to B. pertussis and to Ciliated Cells . For these assays, suspensions of bacteria or ciliated cells in Medium 199S were tested independently. 109 bacteria (0.5 ml) or 105 ciliated cells (0.5 ml) were incubated for 30 min with potential inhibitors of adherence listed in Tables I and II , then with FHA (50 ug/ml), PT (5 ug/ml) (courtesy of Dr. J. Cowell, Bureau of Biologics, Bethesda, MD), or no addition for 30 min. Samples were washed twice (bacteria: 10,000 g; cells : 250 g; both for 10 min at 4°C), then exposed to 10 ul ofantibody to FHA or to PT (goat gamma globulin fraction as per reference 1, courtesy of Dr. J. Cowell, Bureau of Biologics, Bethesda, MD) for 30 min at 37 oC. The bacteria or cells were then washed, resuspended in 20 ul of Medium 1995, spotted onto a microscope slide, and air dried . Antibody that bound to the bacteria or to the ciliated cells was detected by staining with a 1 :20 dilution offluorescein-conjugated antibody to goat Fc (Cappel Laboratories, Cochranville, PA). Slides were read in a coded fashion by one of us (E. Tuomanen).
Preparation of Glycoconjugate Extracts of Human Ciliary Membranes. Glycoconjugates were extracted from the cilia ofa 0.5 x 5-cm strip ofhuman trachea by an adaptation ofthe method ofRamesha (6) for deciliation oftetrahymena. Ciliated cells were scraped from the cartilagenous support into 20 ml 20 mM Tris, 10 mM EDTA, 125 mM sucrose buffer, pH 7.2. Cells were washed free of debris (centrifuged at 300 g for 5 min) and resuspended in 80 mM acetate, 10 mM EDTA, 125 mM sucrose buffer, pH 6.8, to a final concentration of 106 cells/ml. After incubation for 5 min, 0.2 M CaC12 was added to a final concentration of 10 mM, the mixture was swirled for 10 min, and passed three times through an 18-gauge needle. This procedure releases ti70% of the cilia from cell bodies as determined by light microscopy. The mix-ture was diluted in 3 vol of Tris, EDTA, sucrose buffer (as above), and whole deciliated cells were pelleted at 480 gfor 5 min and stored in saline at 4°C . The supernatant fluid containing the cilia free of cell bodies was centrifuged at 18,000 g for 20 min, and the pellet was stored in saline at 4°C overnight .
The ciliary membrane was extracted by an adaptation of the method ofAdoutte et a1. (7) . The ciliary membrane was removed by vortexing the ciliary pellet in freshly prepared 1 mM Tris, 0.1 mM EDTA, pH 8.3 (Tris-EDTA), for N2 min . This suspension was centrifuged at 48,000 gm. for 30 min to recover all particulate material. The pellet obtained was suspended in 10 mM Tris, pH 8.0, to a concentration of N5-10 mg protein ml-1 , and 0.2-0.3 ml was layered on a sucrose step gradient consisting of 0.7 ml of 66% (wt/wt) sucrose overlaid with 1.7 ml each of 55 and 45% sucrose and 0.7 ml of 20% sucrose in 10 mM Tris, pH 8.0. The gradient was poured and left at 4°C for N1 h before being used. The gradient was centrifuged in an SW 50.1 rotor (Beckman Instruments, Inc., Palo Alto, CA) at 4.5 x 104 rpm for 1.5 h at 4°C to separate the different fractions. Ciliary membranes banded within the 45% sucrose layer, incompletely demembranated cilia banded within the 55% layer, and axonemes banded at the interface of the 55 and 66% layers of sucrose. The bands were collected from the gradient, checked for purity by phase-contrast microscopy, and washed by centrifugation in 20-30 vol of 10 mM Tris, pH 8.0, before gel electrophoresis or lipid extraction.
Fractions enriched in ciliary and cell body membranes were extracted for both glycolipids and glycoproteins. Fractions were extracted three times in chloroform/methanol (C/M) 2:1. The protein precipitate was reserved for later examination, while the lipid extract was evaporated, re-extracted in C/M, and evaporated under a stream of nitrogen . Extracts were subjected to a Folch partition in six parts C/M to one part water (8) . The upper phase was harvested as the glycolipid fraction and repartitioned twice in chloroform/methanol/0 .1 KCl (1 :2:10). Salt was removed by passage through a Sep-Pak C18 cartridge (Waters Associates, Milford, MA) by washing with water. Glycolipids were eluted from the cartridge with methanol and C/M . The eluate was evaporated under nitrogen, resuspended, and separated by TLC carried out on high performance thin layer chromatography plates precoated with Silica gel 60 (Merck & Co., Rahway, NJ), and developed in chloroform/methanol/water (60:40 :9 by vol) (9) .
The protein precipitates ofthe cilia and cell body fractions were suspended in sample buffer containing 2-ME and subjected to gel electrophoresis in SDS according to the method of Laemmli (10) (3 .5% stacking gel, 10% separating gel). Proteins were then electrophoretically transferred to nitrocellulose by the method of Towbin et al. (11) in Tris-glycine-0 .01% SDS transfer buffer. Nitrocellulose strips containing ciliary and cell body glycoproteins were incubated with a 1 :1,000 dilution of mAb for 3 h, the peroxidase conjugated anti-mouse Fc fragment (Cappel Laboratories), and finally peroxidase substrate.
Binding of Bacteria, Isolated Adhesins, or Antibodies to Chromatographed Glycosphingolipids . An adaptation ofthe Magnani technique (12) as described by Hansson et al. (13) was used. TLC plates containing either ciliary or cell body glycolipids, total neutral glycolipids from dog and rat intestine, human meconium, or glycosphingolipid standards (lactosylcemmide, globotriaosylceramide, and Lea pentaglycosylceramide) (13, 14) were dried and exposed to 0.576 (wt/vol) polyisobutyl methacrylate saturated in diethyl ether. The plate was dried thoroughly and sprayed with 1% BSA in PBS, pH 7.3, incubated for 1 h at room temperature, rinsed with PBS, and incubated for 2 h with one of the following in 1 % BSA in 20 ml PBS: (a) a suspension of 108 radiolabeled B. pertussis, (b) 50 pl/ml FHA or 20 ug/ml PT; or (c) 1 :1,000 dilution of anticarbohydrate antibody. The plate was washed upside down and in experiment (a) was dried and autoradiographed using XAR5 X-ray film (Kodak) for 24 h. For experiment (b), plates were incubated with 1% BSA in PBS and 11,000 goat anti-FHA or anti-PT antibody for 3 h. The plate was then rinsed with PBS, and samples from experiments (b) and (c) were incubated for 3 h with 1 :100 peroxidase-conjugated anti-goat Fe or anti-mouse Fc antibody, respectively (Cappel Laboratories), were rinsed again, and were exposed to freshly prepared peroxidase substrate (9, 13) .
Chinese Hamster Ovary (CHO) Cell Assay. The CHO cell assay was performed as described (15) . Confluent monolayers, grown in flat-bottomed microtiter plates, were exposed in duplicate to 5 Al of mAbs (Table 11) , anti-FHA, or anti-PT for 1 h. One well of each pair was exposed to 30 ng/ml PT for 30 min. The other well was washed and incubated with 5 P1 fluorescein-conjugated anti-Fc fragment for 1 h. Wells were washed and cellular morphology determined by light microscopy at 6 and 24 h. Fluorescence was assessed qualitatively to determine binding of antibodies to the cell surface.
Results
The Chemical Nature ofthe Receptor. The minimal receptor unit was defined using competition assays in which several types ofagents were used to interfere with B. pertussis adherence to human ciliated cells. Inhibition of adherence was quantitated upon addition ofsimple or complex carbohydrates, lectins, or anti-carbohydrate antibodies. All sugars were tested by pre-incubating the bacteria or the ciliated cells for 30 min at 37°C with 10-2 M sugar. The sugar was then removed and adherence was assessed after 3 h of co-incubation of the bacteria and ciliated cells. Inhibition of adherence was found only if the simple or complex carbohydrates were preincubated with the bacteria, but not with the ciliated cell (Table I) . At high concentrations (10-z M), mannose was found to agglutinate the bacteria, causing an apparent enhancement ofadherence. Comparison ofthe ability ofsimple sugars of the six lectin classes or sialic acid to inhibit adherence indicated that galactose was the single most effective monosaccharide competitive inhibitor. When a dose-response curve was constructed between 10' and 10-2 M, 50 0 7o inhibition of binding occurred at 10-s M galactose. When galactose was added to washed ciliated cells to which bacteria had been previously allowed to adhere, ,10_ z M galactose was able to elute the adherent bacteria from ciliary tufts within 30 min. No change in the number of adherent bacteria occurred in the presence of the other monosaccharides in Table I .
Since the pattern of competitive inhibition by monosaccharides does not necessarily predict the structure of a receptor (16) , the ability of a library ofcomplex carbohydrates containing galactose and N-acetylated amino sugars to inhibit adherence was tested . Many complex carbohydrates containing galactose in 01-4 linkage blocked adherence (Table I) . Lactose was a highly effective competitive inhibitor of adherence. Breast milk, the carbohydrates of which are >90% lactose, decreased binding to 2 % of control values, while breast milk devoid of lactose did not inhibit (91% ofcontrol binding). Lactosamines with or without sialic acid also blocked adherence. However, N-acetylgalactosamine-containing compounds with a 01-3 backbone linkage did not block adherence. Removal of sialic acid from ciliated cells by neuraminidase did not decrease adherence.
The importance ofthe galactose-N-acetylglucosamine moiety to adherence ofB. pertussis to cilia was further demonstrated by testing lectins for their ability to engage the human cell receptor and block adherence. The lectins shown in Table I were incubated with bacteria or ciliated cells, and after washing, bacterial adherence was tested . Two of the seven lectins tested decreased adherence; inhibition occurred only when the ciliated cell and not when the bacterium was incubated with the lectin . The specificity ofthe most effective antiadherence lectin, Lotus tetragonolobus, was fucose-al-2-galactose-01-4-N-acetylglucosamine . Reduced, but detectable, activity was found for peanut agglutinin (recognizes fucosylated galactose 01-3 N-acetylgalactosamine). Thus, a common receptor structure containing part of the lactose structure could be proposed from the studies with the library ofsimple and complex carbohydrates and the lectins. Natural Carbohydrates. Glycolipids were separated by TLC and the ability of radiolabeled whole bacteria, purified adhesins, and anti-carbohydrate antibodies to bind to the plate was tested . Bound whole bacteria were detected by autoradiography in the region of the TLC plate corresponding to lactosylceramide and a species of triglycosylceramide (Fig. 1) . The purified adhesins FHA and PT, either alone or in combination, bound to the same carbohydrate species as the whole bacteria . Activities of the Anti-carbohydrate mAbs in Blocking Adherence. mAbs to human cell surface glycosphingolipids with carbohydrate composition related to lactosamine were tested for three properties expected of antibodies recognizing the B. pertussis receptor : (a) the ability to bind to human ciliary tufts but not ciliated cell bodies ; (b) the ability to bind to extracts of human ciliary membranes; and (c) the ability to block adherence of whole organisms and purified adhesins to cilia. As shown in Table II , a series of antibodies recognizing the Lewis a (Lea), Leb, or A blood group antigens were effective in blocking adherence of B. Pertussis to cilia.
Upon titration of blocking activity, the IC50 for the Lea-specific antibodies 23-24 and 19-11 was the lowest, 0.03 pg/ml, while that for the a Leb-specific antibody 69-4 was 0.5 ug/ml. Antibodies 23-24 and 69-4 were chosen for further study. The localization of binding of antibodies 69-4 and 23-24 to ciliated cells, the latter being the more effective antiadherence antibody, was different. Antibody 23-24 bound to cilia and not to ciliated cell bodies as detected by fluorescein-labeled anti-Fc antibody. The same antibody also bound to a doublet of glycolipids in extracts of ciliary but less to cell body cytoplasmic membrane (Fig. 2) ; antibody 69-4 bound to cell body-related glycolipids. Antibody 23-24 also bound to a single ciliary glycoprotein (not shown) ; 69-4 did not bind . The anti-adherence antibody 23-24 bound to as little as 1 ng of Lewis a antigen on thin layer chromatograms. Antibody 23-24 did not crossreact with the Lewis b antigen, the H antigen (the A and B precursor), or structural isomers of the Lewis a antigen in the TLC assay.
In addition to the ability to block adherence of whole B. Pertussis to cilia, mAbs were tested for the ability to alter adhesin binding to intact ciliated cells as well as for the phenomenon of enhancement of adherence. Purified adhesins have been shown to localize to the ciliary membrane (1, 17, 18) . When preincubated with antibodies 23-24, 19-11, and to alesser extent 69-4, ciliated cells could no longer capture purified adhesins from the medium as detected by immunofluorescence. The capture of adhesins from the medium is known to enhance the binding of virulent B. Pertussis to the adhesin-coated ciliated cell (1). Antibody 23-24 blocked this enhancement phenomenon .
Since PT is an adhesin in the human ciliated cell assay in vitro and antibody 23-24 blocked its association with cilia, we tested if the antibody blocked binding of PT to its specific receptor on CHO cells. Even at high concentrations of antibody (5 mg/ml protein), a low concentration (30 ng/ml) of PT was still able to intoxicate CHO cells as indicated by the development of the characteristic clustering morphology.
Discussion
The development of an in vitro assay quantitating the adherence of B. pertussis to human ciliated cells has led to the elucidation of several aspects of the mechanism by which this interaction is sustained for such an unusually long time in patients with whooping cough. The bacterial side of the interaction involves two secreted proteins, FHA and PT (1). Both are important for adherence to ciliated cells (1), while FHA alone appears to be sufficient for adherence to nonciliated cells (19) . Early evidence suggested that the B. pertussis-cilia interaction was similar to that of classical mucosal pathogens, in that bacterial proteins recognized host cell carbohydrates (4) . This report describes the nature of a family of host cell receptors on human ciliated cells that interact with both adhesins .
Several lines of evidence indicate that part of the lactose moiety is the minimal receptor unit for B. pertussis on human cilia. Carbohydrates that mimicked the receptor and blocked adherence when preincubated with the organism included galactose, galactose (i1-4-glucose, and complex lactosamines . Substitution with sialic acid or mannose did not alter antiadherence activity. Breast milk, in which the carbohydrate is >90% lactose, also was an inhibitor of adherence. Alveolar glycoprotein also contains similar moieties, suggesting endogenous competitive inhibitors of adherence occur in the distal lung where organisms are only rarely found in natural disease (17) . Importantly, the incubation of ciliated cells bearing adherent bacteria with high concentrations of galactose caused elution of the adherent B. pertussis. This suggests that receptor analogs may be candidates for adjuncts to the therapy of B. pertussis.
Masking of the receptor on cilia was achieved by preincubation of ciliated cells within lectins or anti-carbohydrate mAbs recognizing the galactose-glucose structure . Reagents directed against the R1-4 (and, to a lesser extent, the p1-3) configuration were effective inhibitors . A wide variety of saccharide substitutions (fucosylation, N-acetylation, etc.), was acceptable among inhibitors ; such permissiveness has been shown previously for Proprionobacterium granulosum and Escherichia coli adherence to nonciliated cells (20) . This suggested that the core structure of many blood group antigens such as A, B, H, and Lewis could serve as a receptor for B. pertussis, a fact that would explain why virtually all people are susceptible to the disease. In fact, mAbs against the Lewis a (Gal B1-3G1cNAc[4-1-a-Fuc]) and, to a lesser extent, A or Le b antigens, were effective antibody inhibitors of adherence. These antibodies bound to ciliated cells and, in the case of the most effective antibody (anti-Lea), bound to cilia and not ciliated cell bodies . This is consistent with the topographic restriction of the bacteria to ciliary tufts during natural infection. Interestingly, several pneumococcal polysaccharides carry the lactose moiety and block adherence, suggesting that anti-capsular antibody (particularly to types 14 and 19) may affect the adherence of B. pertussis (17) . It remains to be shown if prophylaxis of contacts might be achieved by anti-receptor antibodies or by receptor analogs.
Bordetella demonstrate remarkable species specificity for the target host. Differences in adherence have been clearly shown to parallel the natural pattern of disease (18) , suggesting receptors may differ between infected hosts. Studies by Plotkin and Bemis (21) suggest that N-acetylglucosamine is critical to the receptor of B. bronchiseptica in the hamster. In contrast, the receptor in swine has been characterized as a ganglioside (22) . It is possible that this discrepancy represents a similarity to the situation found for Vibrio cholera, which adheres primarily to the ganglioside GMl but less efficiently to fucosylated nonacidic carbohydrates (23, 24) . In the case of B. pertussu, gangliosides are capable of inhibiting FHA-dependent adherence to nonciliated tissue culture cells (J. Cowell, Bureau ofBiologics, Bethesda, MD, personal communication) . Despite extensive effort, however, we were not able to demonstrate a primary role for sialic acid-containing compounds in adherence of B. pertussis to human cilia either by competition studies or by treatment of cells with neuraminidase. Both FHA and PT, alone or in combination, adhered to purified lactosecontaining glycolipids on TLC plates, suggesting that this receptor can interact with both adhesins. Since adherence to cilia involves two adhesins, FHA and PT, while that to nonciliated cells occurs with FHA alone, it is possible that the binding specificity of PT masks the ganglioside specificity of FHA when human cells are the target or that two carbohydrate specificities exist. We suggest that the latter is more likely for two reasons. Fetuin and haptoglobin not only block adherence but also are known to bind to PT sufficiently well so as to serve as ligands for purification of the toxin by affinity chromatography (25, 26) . Fetuin does not, however, block the binding to and intoxication of CHO cells by PT (27) . This is consistent with our finding that although the antiadherence mAbs bound to CHO cells, they did not prevent intoxication . PT is a structurally complex toxin, and these findings indicate that the PT binding site promoting adherence of the whole organism to cilia is distinct from that associated with ADP-ribosylating activity. This does not rule out the possibility that binding at one site may facilitate binding at the other, since the association of structurally similar glycolipids and glycoproteins as part of a complex linked to intracellular signaling systems has been described (28) .
Summary
The adherence of Bordetella pertussis to human respiratory cilia is critical to the pathogenesis of whooping cough. To explore the development of agents that could interrupt adherence, the structure of the receptor on the ciliary surface was investigated. Using an in vitro adherence assay to human ciliated epithelial cells, galactose, lactose, and complex carbohydrates containing lactose eliminated adherence when preincubated with the bacteria. 10-2 M galactose eluted adherent bacteria from cilia. B. pertussis and its two purified adhesins bound specifically to natural lactosecontaining glycolipids in a TLC assay. mAbs to eukaryotic glycoconjugates with specificity for substituted galactose-glucose moieties blocked adherence when preincubated with ciliated cells. The carbohydrates that serve as receptors for B. pertussis on human cilia are galactose-glucose-containing glycolipids. Receptor analogs and anti-receptor antibodies effectively block adherence of B. pertussis to cilia and thus should be considered candidates for therapeutic intervention against disease.
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